From Financial Modeling Prep: 2024-12-29 07:00:02

Eterna Therapeutics Inc. (NASDAQ:ERNA) boasts a high Return on Invested Capital (ROIC) of 142.52% with a Weighted Average Cost of Capital (WACC) of 4.73%, indicating efficient capital usage. PaxMedica, Inc. (PXMD) surpasses Eterna with an impressive ROIC of 861.32% and a WACC of 5.39%, showcasing superior capital efficiency. Competitors struggle with negative ROIC to WACC ratios, highlighting challenges in value creation.



Read more at Financial Modeling Prep:: Eterna Therapeutics Inc. (NASDAQ:ERNA) and Its Com…